Biography of Sujal Shah

Last update: February 16, 2024

Career

Sujal was Director, Healthcare Investment Banking for Citigroup. Sujal Shah joined CymaBay Therapeutics in 2013. Sujal served as Chief Financial Officer and Interim Chief Executive Officer for CymaBay Therapeutics.

Sujal Shah is currently

Create your alert
to follow the career of Sujal Shah.

Education

Sujal Shah has a Master of Science in Biomedical Engineering from Northwestern University in 1997 and a Master of Business Administration in Finance and Accounting from Carnegie Mellon University - Tepper School of Business in 2004.

They have also studied at Northwestern University :

Find more alumni from Northwestern University


They have also studied at Carnegie Mellon University - Tepper School of Business :

Find more alumni from Carnegie Mellon University - Tepper School of Business

The colleagues of Sujal Shah

Company Colleagues
Homonyms
Industry Colleagues
  • In the Pharmaceuticals industry, Sujal Shah has 19,383 colleagues in 1,868 companies located in 69 countries. 8,394 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Sujal Shah.

Get in Touch

Use our Premium/VIP Service to contact Sujal Shah by email now. Here are a few tips for establishing great contacts.

Send an email
to Sujal Shah.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.